undamentalytics Newsletter
Sign in

Nutriband Inc. key statistics and ratios

In fiscal 2026, Nutriband Inc. had return on equity of -125.6%, an operating margin of -408.4%, debt equal to 0.5% of equity and a current ratio of 6.36. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Jan 20192020Jan 20202021Jan 20212022Jan 20222023Jan 20232024Jan 20242025Jan 20252026Jan 2026LTMJul 2026
Gross margin−17.5%—33.5%39.0%36.1%41.3%34.7%27.8%33.1%
Operating margin<−999%<−999%−275.1%−429.7%−215.2%−233.6%−480.7%−408.4%−435.6%
Net margin<−999%<−999%−310.8%−434.3%−215.6%−263.0%−489.9%−404.1%−430.4%
Free-cash-flow margin−452.4%——−203.3%−147.5%−171.6%−220.5%−252.4%−224.5%
Return on equity−138.5%—−80.5%−65.1%−43.9%−73.1%−162.9%−125.6%−116.0%
Return on assets−118.7%−108.7%−48.4%−54.5%−40.4%−64.6%−139.9%−109.6%−100.6%
Asset turnover0.090.050.160.130.190.250.290.270.23
Current ratio1.470.020.127.013.601.024.886.364.21
Debt to equity0.0%—2.1%0.9%1.2%32.3%0.9%0.5%2.9%
Interest cover (operating income ÷ interest)—n/mn/mn/mn/mn/mn/mn/mn/m
R&D as % of revenue———28.9%47.2%94.0%145.8%92.9%75.1%
SG&A as % of revenue>999%>999%308.6%282.9%188.3%181.0%201.6%343.4%393.6%
Capital spending as % of revenue1.7%——5.7%3.8%2.5%4.3%0.3%0.0%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

5 of 7 checks passed · July 31, 2026
What it owns · $6m
Short-term assets $4mLonger-term assets $2m
What it owes, and who funded it · $6m
Short-term liabilities $1mLonger-term liabilities $0mShareholders' equity $5m
  • Short-term assets cover short-term liabilities $4m of assets due within a year against $907,048 of liabilities due within a year.
  • Short-term assets cover long-term liabilities $4m short-term assets against $57,310 of longer-dated liabilities.
  • More cash than debt $3m of cash against $25,099 of debt.
  • Debt below 40% of shareholders' equity Debt is 0% of equity.
  • Debt burden no higher than five years ago Debt to equity moved from 1% to 0% over five years.
  • A year's operating cash flow covers at least 20% of debt −$4m of operating cash flow against $25,099 of debt.
  • Operating profit covers interest at least five times over Operating income of −$7m against $20,764 of interest.

From Nutriband Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

8 /100

Weak moat

How hard Nutriband's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 0 / 20

    Net income has been a median -74.1% of total assets over 10 years.

  • Durability 10 / 20

    Operating margin has been a median -399.0%; its worst year was -2414.2%.

  • Cash conversion 0 / 20

    Free cash flow was positive in 0 of 5 years, at a median -224.5% of revenue.

  • Discipline 0 / 20

    The diluted share count rose 67.9% over five years; stock-based pay has been a median 65.9% of revenue.

AI disruption exposure: Medium. In this industry, AI could change how the product is made or sold, without replacing the core asset. The score above includes a 5-point deduction for that exposure (12 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: LPCN vs NTRBNTRB vs SXTCNTRB vs SXTPEYPT vs NTRB

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Nutriband Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nutriband Inc.